PNL5 ASSESSING ABSOLUTE REDUCTIONS IN CLINICAL EFFECT- A MODEL FOR COMPARING THE COST-EFFECTIVENESS OF DISEASE MODIFYING DRUGS (DMDS) UTILIZED IN THE TREATMENT OF MULTIPLE SCLEROSIS (MS)
Abstract
Authors
LD Goldberg KS Akhras A AL-Sabbagh B Hall